Update of Epidemiology, Diagnosis, and Treatment of Pertussis

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 1996 Mar 1

PMID 8740851

Citations 5

Authors

J E Hoppe

Affiliations

Soon will be listed here.

Citing Articles

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Mattoo S, Cherry J Clin Microbiol Rev. 2005; 18(2):326-82.

PMID: 15831828 PMC: 1082800. DOI: 10.1128/CMR.18.2.326-382.2005.

Polymorphism in the pertussis toxin promoter region affecting the DNA-based diagnosis of Bordetella infection.

Nygren M, Reizenstein E, Ronaghi M, Lundeberg J J Clin Microbiol. 2000; 38(1):55-60.

PMID: 10618063 PMC: 86018. DOI: 10.1128/JCM.38.1.55-60.2000.

Comparison of three media for agar dilution susceptibility testing of Bordetella pertussis using six antibiotics.

Hoppe J, Paulus T Eur J Clin Microbiol Infect Dis. 1998; 17(6):391-3.

PMID: 9758277 DOI: 10.1007/BF01691567.

State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Hoppe J Infection. 1998; 26(4):242-6.

PMID: 9717684 DOI: 10.1007/BF02962373.

Laboratory diagnosis of pertussis: state of the art in 1997.

Muller F, Hoppe J, Wirsing von Konig C J Clin Microbiol. 1997; 35(10):2435-43.

PMID: 9316885 PMC: 229988. DOI: 10.1128/jcm.35.10.2435-2443.1997.

References

Trollfors B . Whooping cough--aspects of pathogenesis and treatment. Acta Otolaryngol Suppl. 1984; 407:33-9. DOI: 10.3109/00016488409124962. View

Sprauer M, Cochi S, Zell E, Sutter R, Mullen J, Englender S . Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child. 1992; 146(2):177-81. DOI: 10.1001/archpedi.1992.02160140043018. View

Deville J, Cherry J, Christenson P, Pineda E, Leach C, Kuhls T . Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis. 1995; 21(3):639-42. DOI: 10.1093/clinids/21.3.639. View

Hoppe J, Tschirner T . Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis. 1995; 14(9):775-9. DOI: 10.1007/BF01690992. View

He Q, Mertsola J, Himanen J, Ruuskanen O, Viljanen M . Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis. Eur J Clin Microbiol Infect Dis. 1993; 12(9):690-5. DOI: 10.1007/BF02009381. View

Regan J, Lowe F . Enrichment medium for the isolation of Bordetella. J Clin Microbiol. 1977; 6(3):303-9. PMC: 274757. DOI: 10.1128/jcm.6.3.303-309.1977. View

Bergquist S, Bernander S, Dahnsjo H, Sundelof B . Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J. 1987; 6(5):458-61. DOI: 10.1097/00006454-198705000-00009. View

Hoppe J, Haug A . Antimicrobial susceptibility of Bordetella pertussis (Part I). Infection. 1988; 16(2):126-30. DOI: 10.1007/BF01644321. View

Christie C, Marx M, Marchant C, Reising S . The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children. N Engl J Med. 1994; 331(1):16-21. DOI: 10.1056/NEJM199407073310104. View

10.

Hoppe J, Eichhorn A . Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis. 1989; 8(7):653-4. DOI: 10.1007/BF01968151. View

11.

Granstrom G, Wretlind B, SALENSTEDT C, Granstrom M . Evaluation of serologic assays for diagnosis of whooping cough. J Clin Microbiol. 1988; 26(9):1818-23. PMC: 266723. DOI: 10.1128/jcm.26.9.1818-1823.1988. View

12.

Jenkinson D . Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed). 1988; 296(6622):612-4. PMC: 2545243. DOI: 10.1136/bmj.296.6622.612. View

13.

Hoppe J, Simon C . In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones. Antimicrob Agents Chemother. 1990; 34(11):2287-8. PMC: 172042. DOI: 10.1128/AAC.34.11.2287. View

14.

Isacson J, Trollfors B, TARANGER J, Zackrisson G, Lagergard T . How common is whooping cough in a nonvaccinating country?. Pediatr Infect Dis J. 1993; 12(4):284-8. DOI: 10.1097/00006454-199304000-00005. View

15.

Wolfson J . Quinolone antimicrobial agents: adverse effects and bacterial resistance. Eur J Clin Microbiol Infect Dis. 1989; 8(12):1080-92. DOI: 10.1007/BF01975175. View

16.

MORTIMER Jr E . Pertussis and its prevention: a family affair. J Infect Dis. 1990; 161(3):473-9. DOI: 10.1093/infdis/161.3.473. View

17.

Hoppe J, Haug A . Treatment and prevention of pertussis by antimicrobial agents (Part II). Infection. 1988; 16(3):148-52. DOI: 10.1007/BF01644089. View

18.

Appleman M, Hadfield T, Gaines J, Winn R . Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs. Diagn Microbiol Infect Dis. 1987; 8(2):131-3. DOI: 10.1016/0732-8893(87)90162-3. View

19.

Hoppe J, Halm U, Hagedorn H . Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection. 1989; 17(4):227-31. DOI: 10.1007/BF01639525. View

20.

Peters D, Friedel H, McTavish D . Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1992; 44(5):750-99. DOI: 10.2165/00003495-199244050-00007. View